Adderall vs Vyvanse vs Concerta — The Honest Comparison

The three medications at a glance

Adderall (amphetamine)

• Active ingredient: Mixed amphetamine salts
• Forms: Immediate release (IR) and extended release (XR)
• Duration: IR 4-6 hours, XR 10-12 hours
• Mechanism: Increases dopamine and norepinephrine release plus blocks reuptake
• Abuse potential: Moderate to high (higher for IR)

Vyvanse (lisdexamfetamine)

• Active ingredient: Lisdexamfetamine (prodrug)
• Forms: Capsule (and chewable in some markets)
• Duration: 10-14 hours
• Mechanism: Converts to dextroamphetamine in body via enzymatic process
• Abuse potential: Lower than other amphetamines (prodrug structure)
• FDA approval: Also approved for binge eating disorder

Concerta (methylphenidate)

• Active ingredient: Methylphenidate extended-release
• Forms: Tablet with OROS delivery system
• Duration: 10-12 hours
• Mechanism: Blocks dopamine and norepinephrine reuptake (different mechanism from amphetamines)
• Abuse potential: Moderate, lower than IR amphetamines

How they actually differ

• Drug class: Adderall and Vyvanse are amphetamines. Concerta is methylphenidate (different class).
• Duration profile: All three are extended-release; specific kinetics differ.
• Onset: Concerta gradual rise; Adderall XR has initial peak; Vyvanse smoother onset.
• Peak vs sustained: Adderall has more peak-trough variation; Vyvanse smoothest.
• Abuse potential: Vyvanse lowest, IR Adderall highest.
• Side effect profile: Individual but Concerta often less appetite suppression than amphetamines.

The one mechanism difference that explains most of the rest

Almost every practical difference between these medications traces back to a single split. Methylphenidate (Concerta, Ritalin, and Focalin) is primarily a reuptake blocker: it sits on the dopamine and norepinephrine transporters and slows the reabsorption of what your neurons have already released. Amphetamines (Adderall, Vyvanse, Dexedrine) block reuptake too, but they also act as releasing agents— they actively push additional dopamine and norepinephrine out into the synapse.

That extra push is why many adults describe amphetamines as feeling “stronger” or more noticeable, and methylphenidate as feeling more like a clean lifting of static. It is not a quality judgement, and stronger is not better — a medication that gives you a distinct push can also give you more jaw tension, more evening rebound, and more appetite loss. Plenty of adults who found Adderall too sharp settle comfortably on Concerta at an equivalent clinical benefit, and plenty of adults who felt nothing at all on methylphenidate respond immediately to an amphetamine. Non-response to one class genuinely does not predict non-response to the other, which is the single most useful thing to know if your first medication disappointed you.

Concerta vs Vyvanse: the head-to-head

This is the comparison people search for most, and the two medications are more different than their similar 10–12 hour durations suggest. They sit on opposite sides of the class split above: Concerta is methylphenidate delivered through an OROS osmotic-pump tablet; Vyvanse is lisdexamfetamine, an amphetamine bound to the amino acid lysine, inert until your body cleaves that bond in the bloodstream.

The release curves differ in shape, not just length. Concerta’s OROS shell releases an immediate outer coating first, then pushes drug out at a gradually increasingrate through the day — an ascending profile designed to counter the tolerance that builds over a single dose. Vyvanse rises more slowly still, because nothing happens until enzymatic conversion begins, and it comes down as gradually as it went up. In practice, adults often report Concerta arriving faster in the morning, and Vyvanse feeling smoother end-to-end with the gentlest offset of any stimulant in common use.

The prodrug design is not marketing.Because lisdexamfetamine must be metabolised before it does anything, crushing, snorting, or injecting it does not produce a faster or bigger effect. It is the reason Vyvanse carries the lowest misuse potential of the stimulants here and the reason it is frequently the first choice for adults with a substance-use history — a genuinely meaningful clinical advantage rather than a branding one.

Where each tends to win.Vyvanse is often preferred when the problem with a previous medication was harshness: a jittery onset, a hard afternoon drop, or an all-or-nothing feel. Concerta is often preferred when appetite suppression was the deal-breaker, when an amphetamine amplified anxiety, or when cost matters — generic methylphenidate ER is usually substantially cheaper than brand lisdexamfetamine, though generic lisdexamfetamine has been changing that picture. None of these tendencies override individual response, which is why the honest answer to “which is better?” is the unsatisfying one: whichever one works for you, and you find that out by trying.

Concerta vs Adderall

Adderall is a 3:1 mix of dextro- and levo-amphetamine salts. The IR version runs 4–6 hours; the XR capsule contains two bead types — half releasing immediately, half releasing about four hours later — which produces a double-peak curve rather than a single arc.

Against Concerta’s ascending OROS release, that difference is what adults actually feel. Adderall XR tends to hit harder and earlier, with a more defined peak and, for some, a more noticeable trough when the second pulse fades. Concerta’s curve is flatter and later-weighted. If the complaint about a medication is “it comes on too fast and I can feel it wearing off,” the ascending profile is often the more comfortable fit. If the complaint is “it never quite kicked in,” an amphetamine’s releasing action may be the missing piece.

On the common question of which is “stronger”: milligram for milligram, amphetamine is roughly twice as potent as methylphenidate, which is why Concerta doses (18–72 mg) look so much larger than Adderall doses (5–30 mg). That is a units difference, not a statement about which controls symptoms better. Comparing the numbers on two prescription labels tells you almost nothing clinically useful.

Concerta vs Ritalin (and where Focalin fits)

Concerta and Ritalin are the same active molecule — methylphenidate. The entire difference is delivery. Ritalin is immediate-release: it comes up within roughly half an hour, runs about 3–4 hours, and then leaves, which is why it typically requires two or three doses a day and produces a visibly stop-start pattern. Concerta packages the same molecule in the OROS system for a single morning dose covering the working day.

Neither is inherently better. Immediate-release methylphenidate offers something the long-acting formulations cannot: control. You can take it when you need it and skip it when you don’t, which suits shift workers, adults whose demands cluster unpredictably, and anyone who wants their evening appetite and sleep drive back. What it costs you is consistency — the mid-morning dip while you wait for the next dose is a real and unpleasant part of many people’s day, and remembering a midday dose is an executive-function task handed to the person whose executive function is the reason they’re medicated in the first place.

Focalin is dexmethylphenidate: the isolated d-isomer, the half of the methylphenidate molecule that does most of the work. Because the inactive half is removed, it is roughly twice as potent by weight, so Focalin doses look about half the size of the Ritalin equivalent. Some adults find it cleaner; others notice no difference at all. It is a variation within the methylphenidate family, not a third class.

How long each one lasts — and what the drop feels like

The headline durations are the easy part: Adderall IR 4–6 hours, Adderall XR 10–12, Concerta 10–12, Vyvanse 10–14, Ritalin 3–4. What those numbers hide is the shape of the exit, which is what people mean when they talk about the “crash.”

A stimulant crash is the offset happening faster than your nervous system can adjust to, and it shows up as sudden fatigue, irritability, a flat mood, a rebound of the ADHD symptoms the dose had been holding, and often a strong wave of hunger. The steeper the fall, the more it registers. Immediate-release amphetamines fall the most sharply. Adderall XR can produce a distinct late-afternoon drop as the delayed bead pulse clears. Concerta’s ascending curve means it is still climbing when many medications are levelling off, so its wear-off tends to arrive later in the evening. Vyvanse’s gradual enzymatic conversion gives it the gentlest offset of the group, which is exactly why adults who crashed hard on other stimulants are so often moved to it.

The crash is also frequently not pharmacology at all. A stimulant that suppressed your appetite through lunch, kept you working through the breaks you would otherwise have taken, and pushed a poor night’s sleep out of view will hand all of that back at 5pm. Before concluding a medication is wrong for you, it is worth eating properly during the day and seeing whether the crash survives it — often a good part of it does not.

Dose equivalence: what the conversion charts don’t tell you

“What’s 36 mg of Concerta in Vyvanse?” is one of the most common questions asked about these drugs, and it deserves an honest answer rather than a tidy table. There is no validated, regulator-endorsed conversion between methylphenidate and amphetamine. The rough two-to-one potency relationship is a real pharmacological observation and a useful sanity check, but it is not a switching protocol, and it says nothing about how youwill respond — individual variation in stimulant response is wide enough to swamp any conversion arithmetic.

This is why prescribers who switch you across classes will usually restart titration from a low dose rather than convert your old dose across. That can feel like a step backwards when you have already done the dose-finding work once. It isn’t: a fresh titration on a molecule your body handles differently is the shortest route to the right dose, and the alternative — landing on a converted dose that is wrong in either direction — is what makes people give up on a medication that would have suited them at a different number.

Appetite, weight, and anxiety — the two side effects that decide most switches

Appetite.All stimulants suppress appetite; the amphetamines generally do so more than methylphenidate. For most adults this shows up as simply not registering hunger during the medicated hours, then eating heavily in the evening once it lifts. This matters more than it sounds: chronic under-eating during the day makes the afternoon drop worse, and a body that gets its calories at 9pm sleeps badly. If weight loss is unintended and continuing, that is a prescriber conversation, not something to push through — and it is a common, legitimate reason to move from an amphetamine to methylphenidate. (Vyvanse is separately FDA-approved for binge eating disorder in adults, which is a distinct clinical use and not a weight-loss indication.)

Anxiety.Any stimulant can raise baseline anxiety, and some adults find that amphetamines do it more insistently than methylphenidate — though the reverse pattern is common enough that nobody should assume. What is genuinely worth knowing is that stimulant-driven anxiety often turns out to be a dose problem rather than a drug problem: too high a dose produces a wired, edgy, over-focused state that is easy to mistake for “I can’t tolerate stimulants.” Before abandoning the class, it is worth finding out what happens at a lower dose, and worth being precise with your prescriber about whenthe anxiety appears — at the peak, on the way down, or all day — because each of those points at a different adjustment.

Which is right for you?

The answer is individual. Factors:

• Previous experience (worked or didn’t)
• Substance use history (Vyvanse safer)
• Cardiac history
• Anxiety baseline
• Sleep sensitivity
• Cost and insurance coverage
• Specific symptom profile
• Drug interactions with other medications

Side effect comparisons

Appetite suppression

Amphetamines (Adderall, Vyvanse) typically more than methylphenidate (Concerta). Most patients experience some appetite suppression; severity varies.

Sleep disruption

All three can disrupt sleep. Timing of dose matters — taking late in the day worsens sleep. Vyvanse’s longer duration means later-day effect persistence.

Anxiety and mood

All three can produce anxiety, jitteriness, or mood changes. Adults with anxiety baseline may do better on lower doses or non-stimulants.

Cardiovascular

All three raise heart rate and blood pressure modestly. Cardiac history warrants baseline cardiac assessment before starting and monitoring during use.

Switching between them

Common and straightforward. Stop one, start the other. Conversion ratios exist (rough equivalences):

• 10mg Adderall XR ≈ 30mg Vyvanse ≈ roughly 20–30mg Concerta (amphetamine is about twice as potent by weight as methylphenidate)
• All three are Schedule II controlled substances in the US
• Individual response varies enough that prescriber typically restarts dose-finding

What if none of them work?

About 20-30% of ADHD adults don’t respond well to stimulants generally. Options:

• Try non-stimulants (atomoxetine, guanfacine, bupropion)
• Reconsider diagnosis (anxiety or depression may be primary)
• Address co-occurring conditions
• Combine stimulant + non-stimulant
• Work with ADHD-specialist prescriber

FAQ